DK341679A - Vaccine mod streptokokker og fremgangsmaade til fremstilling deraf - Google Patents

Vaccine mod streptokokker og fremgangsmaade til fremstilling deraf

Info

Publication number
DK341679A
DK341679A DK341679A DK341679A DK341679A DK 341679 A DK341679 A DK 341679A DK 341679 A DK341679 A DK 341679A DK 341679 A DK341679 A DK 341679A DK 341679 A DK341679 A DK 341679A
Authority
DK
Denmark
Prior art keywords
sup
broth
cookies
procedures
producing
Prior art date
Application number
DK341679A
Other languages
Danish (da)
English (en)
Inventor
D L Kasper
Original Assignee
Harvard College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Harvard College filed Critical Harvard College
Publication of DK341679A publication Critical patent/DK341679A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
    • C07K16/1275—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Streptococcus (G)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/961—Chemistry: molecular biology and microbiology including a step of forming, releasing, or exposing the antigen or forming the hapten-immunogenic carrier complex or the antigen per se

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK341679A 1978-08-16 1979-08-15 Vaccine mod streptokokker og fremgangsmaade til fremstilling deraf DK341679A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/934,214 US4207414A (en) 1978-08-16 1978-08-16 Polysaccharide antigens

Publications (1)

Publication Number Publication Date
DK341679A true DK341679A (da) 1980-02-17

Family

ID=25465175

Family Applications (1)

Application Number Title Priority Date Filing Date
DK341679A DK341679A (da) 1978-08-16 1979-08-15 Vaccine mod streptokokker og fremgangsmaade til fremstilling deraf

Country Status (7)

Country Link
US (1) US4207414A (no)
EP (1) EP0008969B1 (no)
JP (3) JPS5533474A (no)
AT (1) ATE7761T1 (no)
CA (1) CA1154382A (no)
DE (1) DE2967036D1 (no)
DK (1) DK341679A (no)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4324887A (en) * 1978-08-16 1982-04-13 President And Fellows Of Harvard College Type II group B Streptococci polysaccharide
US4439422A (en) * 1980-01-02 1984-03-27 Research Corporation Group B Streptococcus antigens and vaccines
US4413057A (en) * 1980-04-14 1983-11-01 Merck & Co., Inc. Group B streptococcal capsular polysaccharides
PT72812B (en) * 1980-04-14 1983-02-16 Merck & Co Inc Process for preparing group b streptococcal capsular polysccha-rides
US4396763A (en) * 1981-01-14 1983-08-02 Meiji Milk Products Company Limited High molecular polysaccharide MPS-80
US4425330A (en) 1981-05-20 1984-01-10 Cornell Research Foundation, Inc. Bovine mastitis vaccine and method for detecting efficacy thereof
US4476119A (en) * 1981-08-04 1984-10-09 Fidia S.P.A. Method for preparing ganglioside derivatives and use thereof in pharmaceutical compositions
US4716223A (en) * 1981-08-04 1987-12-29 Fidia, S.P.A. Method for preparing ganglioside derivatives and use thereof in pharmaceutical compositions
US5302386A (en) * 1986-04-16 1994-04-12 Brigham And Women's Hospital, Inc. Bacterial antigens, antibodies, vaccines and methods of manufacture
JP2754000B2 (ja) * 1986-04-16 1998-05-20 ザ ブリガム アンド ウィメンズ ホスピタル，インコーポレイテッド 細菌抗原、抗体、ワクチン及びその製造方法
FR2627779B1 (fr) * 1988-02-26 1991-03-15 Sodima Union Coop Agricoles Procede d'epaississement d'un produit du type lait fermente, notamment de yaourt et nouveau polysaccharide utile pour la mise en oeuvre de ce procede
US5648241A (en) 1989-09-15 1997-07-15 The General Hospital Corporation Conjugate vaccine against group B streptococcus
US5212075A (en) * 1991-04-15 1993-05-18 The Regents Of The University Of California Compositions and methods for introducing effectors to pathogens and cells
CA2145397C (en) * 1992-09-24 2007-10-30 Harold J. Jennings Group b streptococcus type ii and type v polysaccharide-protein conjugate vaccines
ZA937034B (en) * 1992-09-24 1995-06-23 Brigham & Womens Hospital Group B streptococcus type II and type V polysaccharide-protein conjugate vaccines
US6284884B1 (en) 1995-06-07 2001-09-04 North American Vaccine, Inc. Antigenic group B streptococcus type II and type III polysaccharide fragments having a 2,5-anhydro-D-mannose terminal structure and conjugate vaccine thereof
US6426074B1 (en) * 1997-03-19 2002-07-30 The Brigham And Women's Hospital Inc. Group B Streptococcus vaccine
US7204993B2 (en) * 2004-03-18 2007-04-17 The United States Of America As Represented By The Secretary Of Agriculture Streptococcus agalactiae vaccine
EP1812057A4 (en) 2004-11-01 2009-07-22 Brigham & Womens Hospital MODIFIED STREPTOCOCCAL POLYSACCHARIDES AND USES THEREOF

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE191752C (no) *
CH131283A (de) * 1928-03-06 1929-01-31 Elektro Osmose Aktiengesellsch Verfahren zur Reindarstellung von spezifischem Streptokokken-Pseudoglobulin aus Blutserum, sowie aus Exsudaten und Transsudaten erkrankter Individuen.
US3301848A (en) * 1962-10-30 1967-01-31 Pillsbury Co Polysaccharides and methods for production thereof
US3856775A (en) * 1969-07-14 1974-12-24 Ajinomoto Kk {62 -(1{43 3)-glucans

Also Published As

Publication number Publication date
EP0008969B1 (en) 1984-06-06
JPS6485925A (en) 1989-03-30
JPH0674211B2 (ja) 1994-09-21
EP0008969A3 (en) 1980-08-06
US4207414A (en) 1980-06-10
CA1154382A (en) 1983-09-27
JPH0561255B2 (no) 1993-09-06
DE2967036D1 (en) 1984-07-12
EP0008969A2 (en) 1980-03-19
JPS6485924A (en) 1989-03-30
ATE7761T1 (de) 1984-06-15
JPS5533474A (en) 1980-03-08
JPH0351692B2 (no) 1991-08-07

Similar Documents

Publication Publication Date Title
DK341679A (da) Vaccine mod streptokokker og fremgangsmaade til fremstilling deraf
JPS5726623A (en) Vaccine and manufacture
Evans et al. Mechanism of immunologically specific killing of tumour cells by macrophages
NO950739D0 (no) Vaksiner mot gruppe C Neisseria Meningtidis
Corbel The serological relationship between Brucella spp., Yersinia enterocolitica serotype IX and Salmonella serotypes of Kauffmann-White group N
ATE107703T1 (de) Bakterielle antigene, antikörper, impfstoffe und deren herstellung.
Margherita et al. Serological analysis of Butyrivibrio from the bovine rumen
Mukkur Immunogenicity of a chaotropically extracted protective antigen (s) of Pasteurella multocida type A (bovine origin) against experimental pasteurellosis in mice
King et al. Gel diffusion technique in antigen-antibody reactions of Actinomyces species and “anaerobic diphtheroids”
Mirick et al. STUDIES ON A NON-HEMOLYTIC STREPTOCOCCUS ISOLATED FROM THE RESPIRATORY TRACT OF HUMAN BEINGS: II. IMMUNOLOGICAL CHARACTERISTICS OF STREPTOCOCCUS MG
ATE107516T1 (de) Pasteurella-impfstoff.
Weiss Observations on Bacterium melaninogenicum: Demonstration of Fibrinolysin, Pathogenicity and Serological Types.
Henderson The protective value of the Vi and the O antibody in relation to the virulence of strains of Bact. typhosum
SIDDIQUI et al. Serological comparison of selected parasitic and free‐living amoebae in vitro, using diffusion‐precipitation and fluorescent‐antibody technics
US3658986A (en) Immunization methods against toxic effects of bacterial infection
Morgan et al. Immunological relationships of polysaccharides of mucoid organisms of the typhoid-Salmonella group
ATE207119T1 (de) Die herstellung von menschlichen, monoklonalen antikörpern, die gegen das oberflächenantigen von hepatitis b aktiv sind
Totté et al. Analysis of Cellular Responses to Native and Recombinant Proteins of Cowdria ruminantiuma a
Ahsan et al. Immunobiological relationships between Vibrio fluvialis and Vibrio cholerae enterotoxins
Watanabe et al. Serological analysis of supernatant liquids of cultures of El Tor vibrios
SU522233A1 (ru) Штамм бактерий 6071 серотипа 48
Zhukov-Verezhnikov et al. Heterophile antigens of organisms causing particularly dangerous infections and their action on human intestinal tissues
SU770185A1 (ru) Штамм @ @ @ -10034-продуцент моноспецифической агглютинирующей сыворотки
Ben-Efraim et al. The pH 6 antigen in strains of Pasteurella pseudotuberculosis and its relation to biological activities
Jonsson Immunochemical Study of the Structural Specificity of an Anti-Gentamycin Antiserum, Useful Also for Radioimmunoassay of Sisomycin

Legal Events

Date Code Title Description
ATS Application withdrawn